Amlodipine Besylate
Amlodipine Besylate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Amlodipine Besylate; Generic name: AMLODIPINE BESYLATE; Manufacturer: Cipla USA Inc..
| Brand name | Amlodipine Besylate |
|---|---|
| Generic name | AMLODIPINE BESYLATE |
| Manufacturer | Cipla USA Inc. |
| Used for | 1 INDICATIONS AND USAGE Amlodipine besylate, USP is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension ( 1.1 ) Amlodipine besylate tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Coronary Artery Disease ( 1.2 ) Chronic Stable Angina Vasospastic Angina (Prinzmetal's or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40% 1.1 Hypertension Amlodipine |
| Dosage | 2 DOSAGE AND ADMINISTRATION Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. ( 2.1 ) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. ( 2.1 ) Pediatric starting dose: 2.5 mg to 5 mg once daily. ( 2.2 ) Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. ( 2.2 ) 2.1 Adults The usual initial antihypertensive oral dose of amlodipine besylate tablets is 5 m |
| Active ingredient(s) | AMLODIPINE BESYLATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c8d6b2f-3e4a-47a2-80e2-a34dcb337555 |